Literature DB >> 22936838

Balancing life with glycoconjugates: monitoring unfolded protein response-mediated anti-angiogenic action of tunicamycin by Raman Spectroscopy.

Maria O Longas1, Ashok Kotapati, Kilari Pvrk Prasad, Aditi Banerjee, Jesus Santiago, Krishna Baksi, Dipak K Banerjee.   

Abstract

Asparagine-linked protein glycosylation is a hallmark for glycoprotein structure and function. Its impairment by tunicamycin [a competitive inhibitor of N-acetylglucosaminyl 1-phosphate transferase (GPT)] has been known to inhibit neo-vascularization (i.e., angiogenesis) in humanized breast tumor due to an induction of ER stress-mediated unfolded protein response (UPR). The studies presented here demonstrate that (i) tunicamycin (i) inhibits capillary endothelial cell proliferation in a dose dependent manner; (ii) treated cells are incapable of forming colonies upon its withdrawal; and (iii) tunicamycin treatment causes nuclear fragmentation. Tunicamycin-induced ER stress-mediated UPR event in these cells was studied with the aid of Raman spectroscopy, in particular, the interpretation of bands at 1672, 1684 and 1694 cm(-1), which are characteristics of proteins and originate from C=O stretching vibrations of mono-substituted amides. In tunicamycin-treated cells these bands decreased in area as follows: at 1672 cm(-1) by 41.85% at 3 h and 55.39% at 12 h; at 1684 cm(-1) by 20.63% at 3 h and 40.08% at 12 h; and also at 1994 cm(-1) by 33.33% at 3 h and 32.92% at 12 h, respectively. Thus, in the presence of tunicamycin, newly synthesized protein chains fail to arrange properly into their final secondary and/or tertiary structures, and the random coils they form had undergone further degradation.

Entities:  

Year:  2012        PMID: 22936838      PMCID: PMC3428797          DOI: 10.1351/PAC-CON-12-01-06

Source DB:  PubMed          Journal:  Pure Appl Chem        ISSN: 0033-4545            Impact factor:   2.453


  38 in total

Review 1.  Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds.

Authors:  Robert G Spiro
Journal:  Glycobiology       Date:  2002-04       Impact factor: 4.313

Review 2.  Toll-like receptors: networking for success.

Authors:  David M Underhill
Journal:  Eur J Immunol       Date:  2003-07       Impact factor: 5.532

Review 3.  Signaling the unfolded protein response from the endoplasmic reticulum.

Authors:  Kezhong Zhang; Randal J Kaufman
Journal:  J Biol Chem       Date:  2004-04-07       Impact factor: 5.157

Review 4.  Intracellular signaling by the unfolded protein response.

Authors:  Sebastián Bernales; Feroz R Papa; Peter Walter
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

Review 5.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.

Authors:  S Hakomori
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

Review 6.  Glycosylation in the control of selectin counter-receptor structure and function.

Authors:  John B Lowe
Journal:  Immunol Rev       Date:  2002-08       Impact factor: 12.988

7.  Effects of glycosylation on peptide conformation: a synergistic experimental and computational study.

Authors:  Carlos J Bosques; Sarah M Tschampel; Robert J Woods; Barbara Imperiali
Journal:  J Am Chem Soc       Date:  2004-07-14       Impact factor: 15.419

Review 8.  Roles of N-linked glycans in the endoplasmic reticulum.

Authors:  Ari Helenius; Markus Aebi
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

9.  Is asparagine-linked protein glycosylation an obligatory requirement for angiogenesis?

Authors:  D K Banerjee; M Vendrell-Ramos
Journal:  Indian J Biochem Biophys       Date:  1993-12       Impact factor: 1.918

Review 10.  The mammalian unfolded protein response.

Authors:  Martin Schröder; Randal J Kaufman
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

View more
  1 in total

1.  N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeutic.

Authors:  Aditi Banerjee; Juan A Martinez; Maria O Longas; Zhenbo Zhang; Jesus Santiago; Krishna Baksi; Dipak K Banerjee
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.